News - Intrexon


Current filters:


Popular Filters

Agilis Biotherapeutics and Intrexon collaborate on rare genetic disease


US synthetic biology companies Agilis Biotherapeutics and Intrexon have entered an exclusive channel…

Agilis BiotherapeuticsBiotechnologyBoardroomFinancialIntrexonManagementRare diseasesResearch

Sun Pharma sets up JV with Intrexon for ocular diseases


Sun Pharmaceutical Industries and Intrexon Corp have formed a joint venture to develop controllable gene-based…

IntrexonPharmaceuticalResearchSun Pharmaceutical Industries

Soligenix and Intrexon collaborate on Melioidosis therapy development


US clinical stage biopharma company Soligenix (OTCBB: SNGX) says it will jointly develop a treatment…

Antibiotics and Infectious diseasesBiotechnologyIntrexonLicensingPharmaceuticalResearchSoligenix

Adeona Pharma and Intrexon collaborate for synthetic DNA-based PAH therapy


USA-based Adeona Pharmaceuticals (NYSE Amex: AEN) and the Human Therapeutics Division of Intrexon Corp…

Adeona PharmaCardio-vascularIntrexonLicensingPharmaceuticalResearchRespiratory and Pulmonary

Back to top